- ICH GCP
- US Clinical Trials Registry
- Researchers
- Georgia
- Head and Neck Neoplasms
Medical specialists from Georgia tagged as investigators in clinical trials studying Head and Neck Neoplasms
Total 6 results
-
Amiran MatitashviliSeen in:
- Tbilisi, Cancer Research Center Ltd.
- Tbilisi, Onc. Scient. Research Center
Trials:- NCT05386550 (Principal Investigator)
- NCT05848011 (Principal Investigator)
Conditions:- Head and Neck Cancer;
- Prostate Cancer Recurrent;
- Immunotherapy;
- Androgen-Independent Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Immune Checkpoint Inhibitor;
- Androgen-Independent Prostatic Neoplasms;
- Androgen-Insensitive Prostatic Cance;
- Inhibitory Checkpoint Molecule
-
Davit GiorgadzeSeen in:
- Tbilisi, New Hospitals
Trials:- NCT05386550 (Principal Investigator)
Conditions: -
Eter NatelauriSeen in:
- Kutaisi, Jsc Evex Hospitals
Trials:- NCT05386550 (Principal Investigator)
Conditions: -
Miranda GogishviliSeen in:
- Tbilisi, High Technology Medical Center, University Clinic
Trials:- NCT05386550 (Principal Investigator)
Conditions: -
Tamar MelkadzeSeen in:
- Tbilisi, LLC Todua Clinic
- Tbilisi, LTD Todua Clinic
- Tbilisi, Todua Clinic
Trials:- NCT05596409 (Principal Investigator)
- NCT05386550 (Principal Investigator)
- NCT05848011 (Principal Investigator)
Conditions:- Metastatic Breast Cancer;
- Head and Neck Cancer;
- Prostate Cancer Recurrent;
- Immunotherapy;
- Androgen-Independent Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Immune Checkpoint Inhibitor;
- Androgen-Independent Prostatic Neoplasms;
- Androgen-Insensitive Prostatic Cance;
- Inhibitory Checkpoint Molecule
-
Tamta MakharadzeSeen in:
- Batumi, High Technology Hospital Medcenter
- Batumi, High Technology Hospital Medcenter LLC
- Batumi, LTD "High Technology Hospital Medcenter"
- Batumi, LTD High Tech Hosp Medcenter
Trials:- NCT05386550 (Principal Investigator)
- NCT05456685 (Principal Investigator)
- NCT05611931 (Principal Investigator)
- NCT03390686 (Principal Investigator)
- NCT05848011 (Principal Investigator)
Conditions:- Head and Neck Cancer;
- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Endometrial Cancer;
- Lung Cancer;
- Non-small Cell Lung Cancer;
- Prostate Cancer Recurrent;
- Immunotherapy;
- Androgen-Independent Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Immune Checkpoint Inhibitor;
- Androgen-Independent Prostatic Neoplasms;
- Androgen-Insensitive Prostatic Cance;
- Inhibitory Checkpoint Molecule
Clinical Trials on Head and Neck Neoplasms
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
IRCCS Policlinico S. MatteoNestlé Health Science Spain; Akern SrlCompletedHead-neck CancerItaly
-
University of California, San FranciscoCompleted
-
AZ Sint-Jan AVRecruiting
-
Mayo ClinicRecruitingCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
IntraGel TherapeuticsNot yet recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHead and Neck CarcinomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Completed